(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are PAVmed, Orchard Therapeutics plc, and Orgenesis.

The three biggest losers today are ShiftPixy, Nemaura Medical, and Perma-Pipe International Holdings.

Winners today

1. PAVmed (PAVMW) – 105.67%

NASDAQ ended the session with PAVmed jumping 105.67% to $0.03 on Friday while NASDAQ rose 1.6% to $13,431.34.

Volume

Today’s last reported volume for PAVmed is 32626 which is 397.12% above its average volume of 6563.

More news about PAVmed.

2. Orchard Therapeutics plc (ORTX) – 97.4%

Orchard Therapeutics plc, a gene therapy company, research, develops, and commercialize hematopoietic stem cell and gene therapies in the United Kingdom, Italy, France, and Germany. It offers OTL-200, an ex vivo autologous hematopoietic stem cell gene therapy for the treatment of patients with metachromatic leukodystrophy under the Libmeldy brand; and Strimvelis, a gammaretroviral vector-based gene therapy for the treatment of adenosine deaminase deficiency. The company's program for neurodegenerative disorders comprises clinical proof of concept-stage program, which includes OTL-203 for the treatment of mucopolysaccharidosis type I and OTL-201 for mucopolysaccharidosis type IIIA, or MPS-IIIA; and pre-clinical program, OTL-204 for the treatment of frontotemporal dementia with progranulin mutations. In addition, it develops program for immunological disorders consist of pre-clinical programs, which includes OTL-104 for Crohn's disease with mutations in the nucleotide-binding oligomerization domain-containing protein 2; and OTL-105 for the treatment of hereditary angioedema. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom.

NASDAQ ended the session with Orchard Therapeutics plc rising 97.4% to $15.95 on Friday while NASDAQ jumped 1.6% to $13,431.34.

Earnings Per Share

As for profitability, Orchard Therapeutics plc has a trailing twelve months EPS of $-11.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -66.71%.

More news about Orchard Therapeutics plc.

3. Orgenesis (ORGS) – 23.03%

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.

NASDAQ ended the session with Orgenesis rising 23.03% to $0.80 on Friday, after two successive sessions in a row of gains. NASDAQ rose 1.6% to $13,431.34, following the last session’s downward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Orgenesis has a trailing twelve months EPS of $-0.51.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.99%.

Moving Average

Orgenesis’s worth is higher than its 50-day moving average of $0.76 and way below its 200-day moving average of $1.33.

More news about Orgenesis.

4. Aspen Group (ASPU) – 12.5%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group jumping 12.5% to $0.18 on Friday while NASDAQ rose 1.6% to $13,431.34.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 22.5%, now sitting on 70.92M for the twelve trailing months.

Volatility

Aspen Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.80%, a positive 1.03%, and a positive 6.40%.

Aspen Group’s highest amplitude of average volatility was 5.80% (last week), 8.03% (last month), and 6.40% (last quarter).

Yearly Top and Bottom Value

Aspen Group’s stock is valued at $0.18 at 17:32 EST, way under its 52-week high of $0.55 and way higher than its 52-week low of $0.03.

Volume

Today’s last reported volume for Aspen Group is 20701 which is 27.19% below its average volume of 28434.

More news about Aspen Group.

5. Pioneer Natural Resources (PXD) – 10.91%

Pioneer Natural Resources Company operates as an independent oil and gas exploration and production company in the United States. The company explores for, develops, and produces oil, natural gas liquids (NGLs), and gas. It has operations in the Midland Basin in West Texas. Pioneer Natural Resources Company was founded in 1997 and is headquartered in Irving, Texas.

NYSE ended the session with Pioneer Natural Resources rising 10.91% to $238.42 on Friday, after five successive sessions in a row of losses. NYSE jumped 0.94% to $15,214.02, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Exxon near $60 billion deal to buy pioneer natural resources: reportExxon Mobil Corp. is close to a deal to buy shale-drilling company Pioneer Natural Resources for about $60 billion, have fallen about 1% year to date, while Pioneer stock is down about 6% in 2023, The S&P 500 SPX, in comparison, is up about 11% year to date.

: stocks of permian peers of pioneer natural resources rally in wake of WSJ report that buyout by Exxon Mobil is closeShares of Permian peers of Pioneer Natural Resources Co. were getting a boost in premarket trading Friday, in the wake of was rose 0.8% ahead of the open, Devon Energy Corp. shares gained 0.9% and Diamondback Energy Inc.’s stock climbed 1.4%.

Earnings Per Share

As for profitability, Pioneer Natural Resources has a trailing twelve months EPS of $23.54.

PE Ratio

Pioneer Natural Resources has a trailing twelve months price to earnings ratio of 10.13. Meaning, the purchaser of the share is investing $10.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.28%.

Volatility

Pioneer Natural Resources’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.17%, a negative 0.56%, and a positive 1.04%.

Pioneer Natural Resources’s highest amplitude of average volatility was 2.17% (last week), 1.32% (last month), and 1.04% (last quarter).

Previous days news about Pioneer Natural Resources

• Why pioneer natural resources (pxd) dipped more than broader market today. According to Zacks on Thursday, 5 October, "From a valuation perspective, Pioneer Natural Resources is currently exchanging hands at a Forward P/E ratio of 10.17. ", "The latest trading session saw Pioneer Natural Resources (PXD Quick QuotePXD – Free Report) ending at $214.96, denoting a -0.17% adjustment from its last day’s close. "

More news about Pioneer Natural Resources.

6. AMC (AMC) – 10.48%

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.

NYSE ended the session with AMC rising 10.48% to $9.17 on Friday while NYSE jumped 0.94% to $15,214.02.

Earnings Per Share

As for profitability, AMC has a trailing twelve months EPS of $-5.52.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AMC’s stock is considered to be oversold (<=20).

Sales Growth

AMC’s sales growth is 21.6% for the ongoing quarter and 15.5% for the next.

Volume

Today’s last reported volume for AMC is 23144400 which is 48.06% above its average volume of 15631300.

Volatility

AMC’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.47%, a negative 0.19%, and a positive 7.85%.

AMC’s highest amplitude of average volatility was 4.02% (last week), 4.51% (last month), and 7.85% (last quarter).

More news about AMC.

7. NuCana plc (NCNA) – 9.07%

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. The company applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing medicines, ProTides, to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil, which is in a Phase 1b/2 study in patients with metastatic colorectal cancer. The company also initiated a randomized Phase 2 study of NUC-3373, in combination with other agents, for the second-line treatment of patients with advanced colorectal cancer; and initiated a Phase 1b/2 modular study of NUC-3373 in combination with the PD-1 inhibitor pembrolizumab for patients with advanced solid tumors and in combination with docetaxel for patients with lung cancer. Its pipeline also comprises NUC-7738, a transformation of 3'-deoxyadenosine that is in the Phase 2 part of a Phase 1/2 study in patients with advanced solid tumors which is evaluating NUC-7738 as a monotherapy and in combination with pembrolizumab. It has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.

NASDAQ ended the session with NuCana plc jumping 9.07% to $0.60 on Friday while NASDAQ rose 1.6% to $13,431.34.

Earnings Per Share

As for profitability, NuCana plc has a trailing twelve months EPS of $-0.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -79.14%.

More news about NuCana plc.

8. Riot Blockchain (RIOT) – 8.05%

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain jumping 8.05% to $9.73 on Friday, following the last session’s downward trend. NASDAQ rose 1.6% to $13,431.34, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-1.64.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.82%.

Moving Average

Riot Blockchain’s worth is way below its 50-day moving average of $12.92 and below its 200-day moving average of $10.07.

Sales Growth

Riot Blockchain’s sales growth is 51.1% for the present quarter and 64.6% for the next.

More news about Riot Blockchain.

9. Pinduoduo (PDD) – 7.81%

PDD Holdings Inc., a multinational commerce group, owns and operates a portfolio of businesses. It operates Pinduoduo, an e-commerce platform that offers products in various categories, including agricultural produce, apparel, shoes, bags, mother and childcare products, food and beverage, electronic appliances, furniture and household goods, cosmetics and other personal care, sports and fitness items and auto accessories; and Temu, an online marketplace. It focuses on bringing businesses and people into the digital economy. The company was formerly known as Pinduoduo Inc. and changed its name to PDD Holdings Inc. in February 2023. PDD Holdings Inc. was incorporated in 2015 and is based in Dublin, Ireland.

NASDAQ ended the session with Pinduoduo jumping 7.81% to $106.04 on Friday, after two sequential sessions in a row of gains. NASDAQ rose 1.6% to $13,431.34, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Pinduoduo has a trailing twelve months EPS of $3.88.

PE Ratio

Pinduoduo has a trailing twelve months price to earnings ratio of 27.33. Meaning, the purchaser of the share is investing $27.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.92%.

Yearly Top and Bottom Value

Pinduoduo’s stock is valued at $106.04 at 17:32 EST, under its 52-week high of $106.38 and way above its 52-week low of $38.80.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Pinduoduo’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for Pinduoduo is 14507100 which is 49.23% above its average volume of 9721070.

Moving Average

Pinduoduo’s worth is way higher than its 50-day moving average of $89.30 and way higher than its 200-day moving average of $82.01.

More news about Pinduoduo.

10. Lyft (LYFT) – 7.76%

Lyft, Inc. operates a peer-to-peer marketplace for on-demand ridesharing in the United States and Canada. The company operates multimodal transportation networks that offer riders personalized and on-demand access to various mobility options. It provides Ridesharing Marketplace, which connects drivers with riders; Express Drive, a flexible car rentals program for drivers; Lyft Rentals that provides vehicles for long-distance trips; and a network of shared bikes and scooters in various cities to address the needs of riders for short trips. The company also integrates third-party public transit data into the Lyft app to offer riders various transportation options. In addition, it offers access to autonomous vehicles; centralized tools and enterprise transportation solutions, such as concierge transportation solutions for organizations; Lyft Pink subscription plans; Lyft Pass commuter programs; first-mile and last-mile services; and university safe rides programs. The company was formerly known as Zimride, Inc. and changed its name to Lyft, Inc. in April 2013. Lyft, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

NASDAQ ended the session with Lyft jumping 7.76% to $11.05 on Friday, after two consecutive sessions in a row of gains. NASDAQ jumped 1.6% to $13,431.34, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Lyft has a trailing twelve months EPS of $-3.46.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -193.79%.

More news about Lyft.

Losers Today

1. ShiftPixy (PIXY) – -17.69%

ShiftPixy, Inc., together with its subsidiaries, provides staffing solutions in the United States. It offers employment administrative services, such as payroll processing, human resources consulting, and workers' compensation administration and coverage. The Company also operates human resources information systems platform to assist in customer acquisition for the onboarding of new clients into the company's closed proprietary operating and processing information system. It primarily serves restaurant and hospitality service industries. The company was incorporated in 2015 and is headquartered in Miami, Florida.

NASDAQ ended the session with ShiftPixy sliding 17.69% to $1.07 on Friday, following the last session’s downward trend. NASDAQ rose 1.6% to $13,431.34, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, ShiftPixy has a trailing twelve months EPS of $-60.93.

Yearly Top and Bottom Value

ShiftPixy’s stock is valued at $1.07 at 17:32 EST, way under its 52-week high of $24.97 and way above its 52-week low of $0.36.

Moving Average

ShiftPixy’s value is way higher than its 50-day moving average of $0.72 and way under its 200-day moving average of $4.79.

Sales Growth

ShiftPixy’s sales growth for the current quarter is negative 35.5%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 58.6%, now sitting on 20.81M for the twelve trailing months.

More news about ShiftPixy.

2. Nemaura Medical (NMRD) – -12.36%

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

NASDAQ ended the session with Nemaura Medical sliding 12.36% to $0.30 on Friday while NASDAQ rose 1.6% to $13,431.34.

Earnings Per Share

As for profitability, Nemaura Medical has a trailing twelve months EPS of $-0.45.

Yearly Top and Bottom Value

Nemaura Medical’s stock is valued at $0.30 at 17:32 EST, way under its 52-week high of $3.43 and way above its 52-week low of $0.27.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Nemaura Medical’s EBITDA is -21.35.

Volume

Today’s last reported volume for Nemaura Medical is 166159 which is 23.75% below its average volume of 217918.

Moving Average

Nemaura Medical’s worth is way below its 50-day moving average of $0.57 and way below its 200-day moving average of $0.93.

More news about Nemaura Medical.

3. Perma-Pipe International Holdings (PPIH) – -9.82%

Perma-Pipe International Holdings, Inc., together with its subsidiaries, engineers, designs, manufactures, and sells specialty piping and leak detection systems. It offers provides and jacketed district heating and cooling piping systems for energy distribution from central energy plants to various locations; and primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, as well as engages in the coating and insulation of oil and gas gathering and transmission pipelines. The company also offers liquid and powder based anti-corrosion coatings for external and internal surfaces of steel pipe, including shapes like bends, reducers, tees, and other spools/fittings that is used in pipelines for the transportation of oil and gas products and potable water. It has operations in the United States, Canada, the Middle East, Europe, India, and internationally. The company was formerly known as MFRI, Inc. and changed its name to Perma-Pipe International Holdings, Inc. in March 2017. Perma-Pipe International Holdings, Inc. was incorporated in 1993 and is headquartered in Niles, Illinois.

NASDAQ ended the session with Perma-Pipe International Holdings falling 9.82% to $6.89 on Friday while NASDAQ rose 1.6% to $13,431.34.

Earnings Per Share

As for profitability, Perma-Pipe International Holdings has a trailing twelve months EPS of $0.58.

PE Ratio

Perma-Pipe International Holdings has a trailing twelve months price to earnings ratio of 11.88. Meaning, the purchaser of the share is investing $11.88 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.83%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Perma-Pipe International Holdings’s EBITDA is 0.66.

More news about Perma-Pipe International Holdings.

4. Koninklijke Philips (PHG) – -7.03%

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

NYSE ended the session with Koninklijke Philips falling 7.03% to $18.33 on Friday, after two successive sessions in a row of gains. NYSE jumped 0.94% to $15,214.02, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Koninklijke Philips has a trailing twelve months EPS of $-2.23.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.09%.

Yearly Top and Bottom Value

Koninklijke Philips’s stock is valued at $18.33 at 17:32 EST, way under its 52-week high of $23.30 and way above its 52-week low of $11.75.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7%, now sitting on 18.37B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Koninklijke Philips’s EBITDA is 132.5.

More news about Koninklijke Philips.

5. Mesa Air Group (MESA) – -5.22%

Mesa Air Group, Inc. operates as the holding company for Mesa Airlines, Inc. that provides regional air carrier scheduled passenger services under capacity purchase agreements with the American Airlines, Inc. and the United Airlines, Inc. The company offers scheduled flight and cargo services. It also engages in the leasing of aircrafts and engine types to third parties. As of September 30, 2022, it operated a fleet of 158 aircraft with approximately 306 daily departures to 107 cities in the United States and Mexico. Mesa Air Group, Inc. was founded in 1982 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Mesa Air Group falling 5.22% to $0.84 on Friday while NASDAQ rose 1.6% to $13,431.34.

Earnings Per Share

As for profitability, Mesa Air Group has a trailing twelve months EPS of $-5.73.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -63.73%.

More news about Mesa Air Group.

6. OneWater Marine (ONEW) – -5.09%

OneWater Marine Inc. operates as a recreational boat retailer in the United States. The company offers new and pre-owned recreational boats and yachts, as well as related marine products, such as parts and accessories. It also provides boat repair and maintenance services. In addition, the company arranges boat financing and insurance; and other ancillary services, including indoor and outdoor storage, and marina, as well as rental of boats and personal watercraft. OneWater Marine Inc. was founded in 2014 and is headquartered in Buford, Georgia.

NASDAQ ended the session with OneWater Marine falling 5.09% to $23.31 on Friday while NASDAQ jumped 1.6% to $13,431.34.

Earnings Per Share

As for profitability, OneWater Marine has a trailing twelve months EPS of $5.06.

PE Ratio

OneWater Marine has a trailing twelve months price to earnings ratio of 4.61. Meaning, the purchaser of the share is investing $4.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.9%.

More news about OneWater Marine.

7. Church & Dwight Company (CHD) – -4.78%

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

NYSE ended the session with Church & Dwight Company falling 4.78% to $85.92 on Friday while NYSE rose 0.94% to $15,214.02.

Earnings Per Share

As for profitability, Church & Dwight Company has a trailing twelve months EPS of $1.81.

PE Ratio

Church & Dwight Company has a trailing twelve months price to earnings ratio of 47.47. Meaning, the purchaser of the share is investing $47.47 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.

More news about Church & Dwight Company.

8. NextCure (NXTC) – -4.55%

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company is developing NC410, an immunomedicine designed to block immune suppression mediated by LAIR-1; NC762, a monoclonal antibody that binds specifically to B7-H4, a protein expressed on multiple tumor types; and NC525, a monoclonal antibody that binds to LAIR-1 to functionally kill AML blast cells and leukemic stem cells while preserving normal blood cells, including hematopoietic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.

NASDAQ ended the session with NextCure dropping 4.55% to $1.26 on Friday, after two sequential sessions in a row of losses. NASDAQ jumped 1.6% to $13,431.34, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, NextCure has a trailing twelve months EPS of $-2.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -41.69%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is 2.9% and a drop 8.1% for the next.

Moving Average

NextCure’s value is way below its 50-day moving average of $1.50 and way under its 200-day moving average of $1.59.

Yearly Top and Bottom Value

NextCure’s stock is valued at $1.26 at 17:32 EST, way below its 52-week high of $3.17 and higher than its 52-week low of $1.16.

More news about NextCure.

9. InVivo Therapeutics Holdings Corp. (NVIV) – -4.35%

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with InVivo Therapeutics Holdings Corp. sliding 4.35% to $1.10 on Friday, after three consecutive sessions in a row of losses. NASDAQ jumped 1.6% to $13,431.34, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, InVivo Therapeutics Holdings Corp. has a trailing twelve months EPS of $-4.23.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.96%.

Yearly Top and Bottom Value

InVivo Therapeutics Holdings Corp.’s stock is valued at $1.10 at 17:32 EST, way below its 52-week high of $6.05 and way higher than its 52-week low of $0.81.

Moving Average

InVivo Therapeutics Holdings Corp.’s value is below its 50-day moving average of $1.21 and way below its 200-day moving average of $1.49.

Earnings Before Interest, Taxes, Depreciation, and Amortization

InVivo Therapeutics Holdings Corp.’s EBITDA is 4.11.

More news about InVivo Therapeutics Holdings Corp..

10. Newell Rubbermaid (NWL) – -4.29%

Newell Brands Inc. engages in the design, manufacture, sourcing, and distribution of consumer and commercial products worldwide. The company operates in five segments: Commercial Solutions, Home Appliances, Home Solutions, Learning and Development, and Outdoor and Recreation. The Commercial Solutions segment provides commercial cleaning and maintenance solutions; closet and garage organization products; hygiene systems and material handling solutions; and connected home and security products under the Mapa, Quickie, Rubbermaid, Rubbermaid Commercial Products, and Spontex brands. The Home Appliances segment offers kitchen appliances under the Calphalon, Crockpot, Mr. Coffee, Oster, and Sunbeam brands. The Home Solutions segment provides food and home storage; fresh preserving; vacuum sealing; and gourmet cookware, bakeware, cutlery, and home fragrance products under the Ball, Calphalon, Chesapeake Bay Candle, FoodSaver, Rubbermaid, Sistema, WoodWick, and Yankee Candle brands. The Learning and Development segment offers writing instruments, including markers and highlighters, pens, and pencils; art products; activity-based adhesive and cutting products; labeling solutions; and baby gear and infant care products under the Aprica, Baby Jogger, Dymo, Elmer's, EXPO, Graco, Mr. Sketch, NUK, Paper Mate, Parker, Prismacolor, Sharpie, Tigex, Waterman, and X-Acto brands. The Outdoor and Recreation segment provides outdoor and outdoor-related products under the Campingaz, Coleman, Contigo, ExOfficio, and Marmot brands. It serves warehouse clubs, department and drug/grocery stores, mass merchants, home centers, commercial products distributors, specialty retailers, office superstores and supply stores, contract stationers, e-commerce retailers, sporting goods, and travel retailers, as well as direct to consumers online, select contract customers, and other professional customers. Newell Brands Inc. was founded in 1903 and is based in Atlanta, Georgia.

NASDAQ ended the session with Newell Rubbermaid dropping 4.29% to $7.59 on Friday, after four successive sessions in a row of losses. NASDAQ jumped 1.6% to $13,431.34, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Newell Rubbermaid has a trailing twelve months EPS of $-0.72.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.65%.

Sales Growth

Newell Rubbermaid’s sales growth is negative 5.9% for the current quarter and negative 5.1% for the next.

More news about Newell Rubbermaid.

Stay up to date with our winners and losers daily report